IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2013 Holdings

Filed 2014-02-14 | 12 holdings | $13.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$13.2M250,00098.1%
Ariad Pharmaceuticals IncCOM04033A100$81.8K12,000,0000.6%
Quest Diagnostics Inc(DGX)COM74834L100$37.5K700,0000.3%
Idenix Pharmaceuticals IncCOM45166R204$30.2K5,050,1000.2%
Vivus IncCOM928551100$23.4K2,573,9430.2%
Merck & Co Inc New(MRK)COM58933Y105$20.0K400,0000.1%
Mallinckrodt PUB LTD CoSHSG5785G107$14.6K280,0000.1%
Bristol Myers Squibb Co(BMY)COM110122108$13.3K250,0000.1%
Pfizer Inc(PFE)COM717081103$12.6K410,0000.1%
Repros Therapeutics IncCOM NEW76028H209$8.4K459,5080.1%
Bio-Reference Labs IncCOM $.01 NEW09057G602$7.3K285,3000.1%
Aveo Pharmaceuticals(AVEOEUR)COM053588109$4.7K2,570,7590.0%